DEFINITIONS.
Before proceeding further it may be advisable to note sorne of the terms in common use. Quack nmedicines was a term at one time given to nostrums sold publicly in the market-place before such time as their proprietors became millionaires. The term Patent medicine is a misnomer, since, as popularly used, it does not apply to products protected by letters patent under the great seal, but to proprietary remedies recommended in the treatment of disease. Anyone is at liberty to make or sell such remedies who pays for the licence, which costs five shillings. A true patent cannot be held as valid unless there is something novel and useful about it, and it seems now to be certain that a drug or chemical substance cannot be patented, but only the process of its manufacture. It has further been decided in the courts of law that if a patent is obtained for the preparation of a certain drug, and if a. characteristic name or trade mark is given to that drug, the State grants fourteen years to the proprietors for the sole right of manufacture, after which time the patent lapses with the trade miark, and both become public property.
Proprietary remedies may be divided into (1) secret, for which a, stamp duty is fixed, beginning at a penny-halfpenny for each shilling retail price; (2) those in which the composition is disclosed (these escape the stamp duty even when they are recommended for the treatment of certain diseases if sold by pharmacists); and (3) patent medicines proper. The owners of proprietary medicines rarely take out a patent: first, because there is nothing novel or useful in their nostrum; and, secondly, because the formula would have to be published, so they apply to it a distinctive name or trade mark. A trade mark need not apply to anything novel or useful; indeed, the substance to which it applies is frequently some common chemical bought by the proprietor ready made. A trade mark, unlike a patent, does not apply for fourteen years only, but is valid for ever. So that, if a proprietor sells a drug which contains no scheduled poison and no large amount of alcohol, and if it is stamped, he possesses absolute proprietary rights and absolute secrecy for ever.
SECRET REMEDIES.
With regard to secret remuedies, it is quite unnecessary for me to point out their evil effects, so I will enumerate two or three typical examples showing how they are of direct interest to the medical man. First, there is the bile-bean bubble, whose proprietor, Fulford, accumulated a vast fortune from a credulous public. I quote this case to illustrate how the press in this country is in the grip of the patentmedicine vendor on account of huge advertising contracts. The Court of Session in Scotland in February, 1905 , was concerned with the bilebean case, in which there was a ruthless exposure of the tricks by which it was exploited on the public. The Press in England, however, was silent on the matter, so that the English public never heard of the case, and are as ignorant of bile beans to-day as they were then. If the company had happened to be a small, non-advertising firm, the evidence would not have been suppressed, as was shown in the case of Tucker v. Wakley and another. The perfectly harmless type of nostrum is illustrated by Munyon's kidney cure. The label says that it cures Bright's disease, all urinary troubles, and pain in the back or groin from kidney disease. According to the analysis of' the British Medical Association, the pilules consist of white sugar. Tasteless quinine, another drug of this class with which, not so many years ago, physicians " cured " their malarial patients, was found to consist of powdered gypsum. I propose now to deal with the cause of the success of these nostrums, and the first essential is that of secrecy. Secrecy is a device to deceive, and is quite unnecessary for the protection of any legitimate remedy.
It has been argued that the physician should be acquainted with the action of a drug and not its composition. Of course, this is simple nonsense, as it Is only by the composition that the action can be known. It should also be remembered that the secret-remedy vendor sells either to the medical profession or to the general public, but rarely to both at the same time; not infrequently they begin by advertising to the medical profession only, but so soon as the general public have become acquainted with the drug the advertising to-the profession ceases, and advertisements appear in the lay papers addressed directly to the general public. In England, for example, Kutnow's powder, which "dissolves and eliminates uric acid,' is advertised in the lay Press, and free samples are sent to all who write for them. 
NON-SECRET PROPRIETARIES.
Proprietary remedies not of a secret nature are those with which the medical profession are mainly concerned; and for the introduction of some of these medical men and the public are indebted to some of the great manufacturing houses which have fully-equipped pharmacological laboratories. Adrenalin, antipyrin, arsacetin, chloral, cocaine, veronal, eserin, the nitrites, novocaine, stovaine, strophanthus, are a few of the remedies which owe their introduction to the pharmacological laboratory. Indeed, it is not too much to say that no drug of importance has been introduced into medicine within the last twenty years except through the laboratory. What, then, can a manufacturer, who has discovered through his pharmacological laboratory a substance which promises to be useful in medicine, do in order to introduce his new drug ? He may, of course, take out a patent for the process of manufacture and give the substance a distinctive name, in which cape, if his patent is valid, he will have the sole right of manufacture for fourteen years, which is sometimes extended. Whether this is a sufficient reward or not I shall not attempt to decide. He may, on the other hand, refrain from taking out a patent and apply to his substance a distinctive name or trado mark, which will remain his private property always.
Not infrequently a manufacturer discovers therapeutical properties in a well-known chemical compound, and after a number of clinical experiments he persuades the medical profession to prescribe his substance under the fancy name which he has given it. Other manufacturers quickly get to know what is going on, and place the same substance on the market under yet another registered name, either devised on purpose or taken from a number of names previously registered and kept in stock for emergencies; the current methods of naming new drugs have led to the greatest confusion and frauds upon the physician and general public. Aspirin, acetysal, xaxa, saletin, salacetin, are some of the names by which acetyl-salicylic acid is known; it is a serious matter to the retail chemist, as he may be required to stock all the different samples of the same drug to meet the views of different prescribers. Aspirin was the original substance introduced into medicine as the result of pharmacological investigations, and around which the literature gathered; the other names are parasitic, and followed later. If a right to use a fancy name is legitimate, this should be confined to aspirin. As an example of old drugs introduced into rnedicine under new names we may take atoxyl, which was prepared so long ago as 1863 by Bechamp, and for which numerous fancy names have since been given. Much confusion has been brought about by the introduction of anti-febrin in 1885 for a very well-known chemical body-acetanilid. It is especially a matter for regret that many firms have made a practice of using names and trade packages which will lead to the introduction of their goods directly to the general public.
STATISTICS.
Before passing on to discuss the attitude which we should take up towards this traffic, I think a few statistics showing the extent of the evil may not be amiss. In the first place we should remember that in no country are more quack or secret remedies advertised to the general public than in this; they number, roughly, 10,000, and about the same number are advertised directly to medical men. In 1894-5 31,592 licences at five shillings each, for the sale or manufacture of proprietary nostrums, were issued. In 1904-5 this number had increased to 40,734, yielding over £210,000 to the revenue. Stamp duties were first imposed in 1793, not with the object of limiting the sale of proprietaries, but for revenue purposes, and they were supposed to yield £15,000. The increase in revenue since then is shown in the following £324,112 This shows that the stamp duties yielded formerly only 2 or 3 per cent. of what they now yield, and it is obvious that they have in no way acted as a deterrent to the sale of quack nostrums.
LAWS.
In deciding the best plan of dealing with the evils which have been enumerated it may be well to examine those Acts which are directly or indirectly concerned with the subject.
The Merchandize Marks Act makes it a criminal offence to apply with intent to defraud a false trade description to anything which is subject to trade manufactmfre or merchandize. The Liverpool Corporation prosecuted certain retailers of proprietaries for selling goods falsely described or obtaining money under false pretences. If only this Act could be altered so as to make it compulsory for the local authorities to take action, much good might be done; but, as it is, the Act, so far as the present purpose is concerned, remains a dead letter. The Sale of Food and Drugs Act, 1875 and 1899, says that no person shall sell, to the prejudice of the purchaser, any article of food or any drug which is not of the nature, substance and quality demanded, but an offence shall not be deemed to be committed in those cases where the drug or food is a proprietary preparation. So that the secret-medicine vendor is deliberately placed outside this Act; his ingredients need not be pure, his tartaric acid may contain lead, and no prosecution will follow; it is the registered and qualified pharmacist who is compelled by law to sell pure drugs. A representative meeting of the British Medical Association suggested that proprietaries should be labelled with the name and quantity of each constituent, and that the label should constitute a warranty sb that the vendor could be prosecuted under the Food and Drugs Act.
The Pharmacy Act of 1868 applies to proprietaries containing scheduled poisons. Proprietaries containing such poisons must be labelled poison, with the name and address of the vendor, and must be sold by a registered pharmaceutical chemist or in the shop of a registered chemist or of a limited company. The Act does not apply to medicines of Letters Patent. Winslow's Soothing Syrup is an example of a typical poisonous proprietary. Owbridge's Lung Tonic formerly contained a scheduled poison, but the composition was changed so as to free their sale from the restrictions of the Pharmacy Act.
The Spirits Act dealing with the sale of strongly alcoholic preparations, medicated wines, and the like, makes an Excise licence necessary, except for physicians, chemists, &c.
POLICY.
The methods which have been proposed to eradicate quackery in its widest sense may be divided into two kinds. Those for the secret nostrums we may consider first. There can be little doubt that if it were made compulsory for the composition to be placed on the packet of each proprietary sold, the greater evils would soon cease. Secondly, the Merchandise Marks Act might be altered, making it compulsory for local authorities to act, and last the exemption clause in the Sale of Food and Drugs Act might be deleted. These are the ideals at which we MH-22b
should aim, and I place them before you to-day for your consideration and discussion. You must remember, however, that vested interests are at stake and most governments are chary of interfering with these. Also the whole of the press may be regarded as antagonistic.
In the case of the non-secret proprietaries, our position is still more delicate. If a firllm or individual introduces a new drug into medicine, he should have all the protection and benefits for his discovery that we can give him, but it is hardly fair that the patent should last for ever, any more than the copyright of a book should, and perhaps the fourteen or twenty-one years which the law at present gives him as sole manufacturer of the article in question by the processes he has patented, meets the justice of the case. Many firms have introduced old and wellrecognized chemical substances into medicine under a trade name; if the drug is prescribed much, other firms introduce the same substance under other names, until we get into a state of hopeless confusion. This confusion of names was one of the reasons for tl.e publication by the Pharmaceutical Society of the Codex, in which a simple name is given for each chemical substance which was not actually patented. Finally, it must be remembered that much of the cure for these evils lies in our hands. We should never prescribe a secret remedy; if it has any beneficial action it must be due to one or more well-known drugs which can be easily ascertained. I think we ought not to prescribe a compound medicine of a proprietary nature, especially such things as compressed tablets, in the original packages: it is a direct means of encouraging self-drugging. We ought not to prescribe a drug with a registered fancy name unless it is held by Letters Patent, but refer to its synonym and prescribe it by its chemical name, unless distinct reasons exist for prescribing the original product. It is to be hoped that some authoritative medical body, such as the British Medical Association, will see fit to publish to the profession before long such a list of synonyms.
(The discussion was adjourned until the next meeting.)
